Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 7/20 | 0.37 |
| ▸ | MMP8 | P22894 | 5/20 | 0.37 |
| ▸ | MMP3 | P08254 | 4/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 4/20 | 0.32 |
| ▸ | MMP9 | P14780 | 3/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | PEPD | P12955 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Foscarnet SCHEMBL7249084 | 1.00 | — | — | |
| Foscarnet SCHEMBL5058619 | 1.00 | BLM (0.39) | BLMTDP1MEN1LMNAHPGD | |
| Foscarnet SCHEMBL2689694 | 1.00 | — | — | |
| Foscarnet SCHEMBL8169999 | 1.00 | BLM (0.39) | BLMTDP1MEN1LMNAHPGD | |
| Foscarnet SCHEMBL3966747 | 0.96 | MEN1 (0.37) | BLMTDP1MEN1LMNAHPGD | |
| Foscarnet SCHEMBL8862809 | 0.96 | MEN1 (0.37) | BLMTDP1MEN1LMNAHPGD | |
| Foscarnet SCHEMBL3678731 | 0.96 | MEN1 (0.37) | BLMTDP1MEN1LMNAHPGD | |
| Foscarnet SCHEMBL23633 | 0.95 | — | — | |
| Foscarnet SCHEMBL8647698 | 0.95 | BLM (0.41) | BLMTDP1MEN1LMNAHPGD | |
| Foscarnet SCHEMBL15531347 | 0.95 | BLM (0.41) | BLMTDP1MEN1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547711-A2 | ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Modex Therapeutics, Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| EP-4547335-A2 | ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Modex Therapeutics, Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| EP-4395826-A1 | HUMAN NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 SPIKE S2 DOMAIN AND USES THEREOF | The UAB Research Foundation (US) | 2024-07-10 | — | — | EP | claimed |
| CN-114447333-B | Sodium ion battery | 天津中电新能源研究院有限公司 | 2024-03-26 | — | — | CN | claimed |
| WO-2024007012-A2 | ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | MODEX THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | claimed |
| WO-2024007013-A2 | ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | MODEX THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | claimed |
| EP-4208479-A1 | HUMAN MONOCLONAL ANTIBODIES TO SARS-COV-2 AND USE THEREOF | The UAB Research Foundation (US) | 2023-07-12 | — | — | EP | claimed |
| WO-2023035016-A1 | HUMAN NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 SPIKE S2 DOMAIN AND USES THEREOF | THE UAB RESEARCH FOUNDATION (US) | 2023-03-09 | — | — | WO | claimed |
| CN-114447333-A | Sodium ion battery | 天津中电新能源研究院有限公司 | 2022-05-06 | — | — | CN | claimed |
| WO-2022051650-A1 | HUMAN MONOCLONAL ANTIBODIES TO SARS-COV-2 AND USE THEREOF | THE UAB RESEARCH FOUNDATION (US) | 2022-03-10 | — | — | WO | claimed |
| WO-2001000622-A1 | PRODRUGS OF CARBAMATE INHIBITORS OF IMPDH | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2001-01-04 | — | — | WO | claimed |
| WO-1999059585-A1 | COMPOSITIONS FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-25 | — | — | WO | claimed |
| EP-0788363-A1 | NOVEL MEDICINAL USE | Astra Aktiebolag (SE) | 1997-08-13 | — | — | EP | claimed |
| US-5591889-A | Method for the synthesis of trisodium phosphonoformate hexahydrate | AKTIEBOLAGET ASTRA (SE) | 1997-01-07 | — | — | US | claimed |
| WO-1996014848-A1 | NOVEL MEDICINAL USE | ASTRA AKTIEBOLAG (SE) | 1996-05-23 | — | — | WO | claimed |
| US-4938758-A | Anti-pathogenic blood collection system and method | AL SIOUFI HABIB (US) | 1990-07-03 | — | — | US | claimed |
| EP-0263873-A4 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD. | AL-SIOUFI HABIB | 1989-07-11 | — | — | EP | claimed |
| US-4806532-A | ADMINISTERING PHOSPHONOFORMIC AND PHOSPHONOACETIC ACID AND SALTS; GLANDULAR DISORDERS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1989-02-21 | — | — | US | claimed |
| EP-0263873-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL-SIOUFI, Habib (US) | 1988-04-20 | — | — | EP | claimed |
| WO-1987006119-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL SIOUFI HABIB | 1987-10-22 | — | — | WO | claimed |